Inhibition of the mTORC pathway in the antiphospholipid syndrome

Comment

Guillaume Canaud et al. N Engl J Med. 2014.

. 2014 Oct 16;371(16):1554-5.

doi: 10.1056/NEJMc1410247.

No abstract available

Comment on

Inhibition of the mTORC pathway in the antiphospholipid syndrome.
Canaud G, Bienaimé F, Tabarin F, Bataillon G, Seilhean D, Noël LH, Dragon-Durey MA, Snanoudj R, Friedlander G, Halbwachs-Mecarelli L, Legendre C, Terzi F. Canaud G, et al. N Engl J Med. 2014 Jul 24;371(4):303-12. doi: 10.1056/NEJMoa1312890. N Engl J Med. 2014. PMID: 25054716
Inhibition of the mTORC pathway in the antiphospholipid syndrome.
Van Laecke S, Nagler EV, Vanholder R. Van Laecke S, et al. N Engl J Med. 2014 Oct 16;371(16):1553. doi: 10.1056/NEJMc1410247. N Engl J Med. 2014. PMID: 25317878 No abstract available.
Inhibition of the mTORC pathway in the antiphospholipid syndrome.
Zuily S, Regnault V, Wahl D. Zuily S, et al. N Engl J Med. 2014 Oct 16;371(16):1553-4. doi: 10.1056/NEJMc1410247. N Engl J Med. 2014. PMID: 25317879 No abstract available.
Inhibition of the mTORC pathway in the antiphospholipid syndrome.
Hidalgo LG. Hidalgo LG. N Engl J Med. 2014 Oct 16;371(16):1554. doi: 10.1056/NEJMc1410247. N Engl J Med. 2014. PMID: 25317880 No abstract available.